Repros Therapeutics, Inc. (RPRX) Reports Q2 Loss of $0.30
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q2 EPS of ($0.30), versus ($0.20) reported last year. Revenue for the quarter came in at $1 thousand, versus $53 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- Twin Disc (TWIN) Tops Q4 EPS by 16c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
